lafutidine and Urticaria

lafutidine has been researched along with Urticaria* in 2 studies

Trials

1 trial(s) available for lafutidine and Urticaria

ArticleYear
Addition of lafutidine can improve disease activity and lead to better quality of life in refractory cholinergic urticaria unresponsive to histamine H1 antagonists.
    Journal of dermatological science, 2016, Volume: 82, Issue:2

    Topics: Acetamides; Adolescent; Adult; Drug Therapy, Combination; Female; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Male; Non-Neuronal Cholinergic System; Piperidines; Pyridines; Quality of Life; Urticaria; Young Adult

2016

Other Studies

1 other study(ies) available for lafutidine and Urticaria

ArticleYear
Retrospective cohort study on combination therapy with the histamine H2-receptor antagonist lafutidine for antihistamine-resistant chronic urticaria.
    The Journal of dermatological treatment, 2013, Volume: 24, Issue:6

    We conducted a retrospective cohort study evaluating the efficacy and usefulness of the addition of lafutidine, a novel histamine H2-receptor antagonist, in treatment of patients with idiopathic chronic urticaria whose disease was not well controlled with histamine H1-receptor antagonists. Based on the assessment of global improvement, moderate or better improvement was achieved in 39 of 46 patients (85%) after 1-3 weeks of additional administration of lafutidine and 35 patients (76%) after 3 months. No incidence of drug-related adverse reactions was reported in any patient. Lafutidine was rated as useful or better in 34 patients (74%) after 3 months of treatment. The usefulness of the drug was not affected by differences in background factors, such as disease duration, previous treatment duration and the number of concomitant H1-receptor antagonists. Lafutidine appears to be a promising addition to histamine H1-receptor antagonist therapy for the treatment of chronic urticaria resistant to treatment with H1-receptor antagonists alone.

    Topics: Acetamides; Adolescent; Adult; Aged; Chronic Disease; Drug Therapy, Combination; Female; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Male; Middle Aged; Piperidines; Pyridines; Retrospective Studies; Urticaria; Young Adult

2013